Sunshine Biopharma, Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-05-29 Financing
SUNSHINE BIOPHARMA INC. Announces Shareholder Approval of Matters Related to Public Offering and Warrants
Material change report - English.pdf
Ownership 2026-05-29
Other securityholders documents - English.pdf
Transactions 2026-05-20 Financing
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
News release - English.pdf
Transactions 2026-05-20 Financing
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
News release - English.pdf
Transactions 2026-05-20 Financing
Material document(s).pdf
Transactions 2026-05-20 Financing
SUNSHINE BIOPHARMA INC. Enters Into Placement Agent Agreement for Public Offering
Material change report - English.pdf
Transactions 2026-05-20 Financing
Material document(s).pdf
Transactions 2026-05-20 Financing
Material document(s).pdf
Ownership 2026-05-19
Other securityholders documents - English.pdf
Ownership 2026-05-19
Other securityholders documents - English.pdf
Ownership 2026-05-19
Other securityholders documents - English.pdf
Ownership 2026-05-18
Other securityholders documents - English.pdf
Ownership 2026-05-18
Other securityholders documents - English.pdf
Ownership 2026-05-18
Other securityholders documents - English.pdf
Ownership 2026-05-18
Other securityholders documents - English.pdf
Ownership 2026-05-18
Other securityholders documents - English.pdf
Ownership 2026-05-18
Other securityholders documents - English.pdf
Ownership 2026-05-18
Other securityholders documents - English.pdf
Ownership 2026-05-18
Other securityholders documents - English.pdf
Ownership 2026-05-18
Other securityholders documents - English.pdf
Results 2026-05-14
Interim MD&A - English.pdf
Results 2026-05-14
Interim financial statements/report – English.pdf
Ownership 2026-04-15
Other securityholders documents - English.pdf
Results 2026-04-09
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
News release - English.pdf
Transactions 2026-04-09 Financing
Material document(s).pdf
Results 2026-04-09
SUNSHINE BIOPHARMA INC. Announces Financial Results for the Year Ended December 31, 2025
Material change report - English.pdf
Results 2026-04-04
Annual MD&A - English.pdf
Results 2026-04-04
Annual report on form 10-K - English.pdf
Results 2026-04-04
Audited annual financial statements – English.pdf
Ownership 2026-04-01
Other securityholders documents - English.pdf
Transactions 2026-03-10 Financing
Sunshine Biopharma Inc. Enters Into Engagement Agreement with Aegis Capital Corp. to Solicit Exercise of Outstanding Warrants
Material change report - English.pdf
Transactions 2026-03-10
Material document(s).pdf
News 2026-03-03
Other securityholders documents - English.pdf
Results 2026-02-20 Returns
SUNSHINE BIOPHARMA INC. Announces Shareholder Approval for Reverse Stock Split
Material change report - English.pdf
News 2026-02-20
Other securityholders documents - English.pdf
Results 2025-11-14 Financials
Interim MD&A - English.pdf
Results 2025-11-14 Financials
Interim financial statements/report – English.pdf
News 2025-10-27
Other securityholders documents - English.pdf
News 2025-10-27
Other securityholders documents - English.pdf
News 2025-10-01
Material change report - English.pdf
News 2025-08-18
Other securityholders documents - English.pdf
Results 2025-08-13 Financials
Interim MD&A - English.pdf
Results 2025-08-13 Financials
Interim financial statements/report – English.pdf
News 2025-08-13
Other securityholders documents - English.pdf
News 2025-08-13
Other securityholders documents - English.pdf
News 2025-08-05
Other securityholders documents - English.pdf
News 2025-08-05
Other securityholders documents - English.pdf
News 2025-08-05
Other securityholders documents - English.pdf
News 2025-08-05
Other.pdf
News 2025-07-28
Other securityholders documents - English.pdf
News 2025-07-28
Other securityholders documents - English.pdf